Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription 13.10.2025 1 Acta Psychiatr Scand 1 Am J Psychiatry 1 Biol Psychiatry 2 Compr Psychiatry 2 Mol Psychiatry 2 Neuropsychopharmacology 1 PLoS One 2 Psychiatry Res 1 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Psychiatr Scand

1. ERCIS M, Miola A, Ortiz-Orendain J, Pazdernik VK, et al
   Three Distinct Pathways to First Episode Mania and Psychosis: Latent Class Analysis of Antecedent Psychopathology.
   Acta Psychiatr Scand. 2025;152:278-289.
   PubMed         Abstract available
   
   

   
   Am J Psychiatry

2. HOWES OD, Bukala BR, Chen EYH, Correll CU, et al
   Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
   Am J Psychiatry. 2025 Oct 8:appiajp20241040. doi: 10.1176/appi.ajp.20241040.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

3. MA Y, Girdhar K, Hoffman GE, Fullard JF, et al
   Sex differences in brain cell-type specific chromatin accessibility in schizophrenia.
   Biol Psychiatry. 2025 Oct 8:S0006-3223(25)01517.
   PubMed         Abstract available
   
   

   
   Compr Psychiatry

4. HE Y, Ng SM, Ran MS, Wang C, et al
   Beyond criticism, hostility, and emotional overinvolvement: Development and psychometric validation of the Comprehensive Expressed Emotion Scale (CEES) in schizophrenia.
   Compr Psychiatry. 2025;143:152638.
   PubMed         Abstract available
   
   
5. HAO J, Bruggeman R, Veling W, Alizadeh BZ, et al
   The power of youth: Long-term differential effects of developmental functioning trajectory on social functioning, quality of life and personal recovery across the schizophrenia spectrum.
   Compr Psychiatry. 2025;143:152637.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

6. WALTHER S, Maderthaner L, Chapellier V, von Kanel S, et al
   Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial.
   Mol Psychiatry. 2025 Oct 8. doi: 10.1038/s41380-025-03303.
   PubMed         Abstract available
   
   
7. MARTINEZ-SADURNI L, Barrera-Conde M, Robledo P, Veza-Estevez E, et al
   Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls.
   Mol Psychiatry. 2025 Oct 7. doi: 10.1038/s41380-025-03287.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

8. O'BRIEN KJ, Huque ZM, Pike MR, Smith EC, et al
   Synergistic pathways to psychosis: understanding developmental risk and resilience factors.
   Neuropsychopharmacology. 2025 Oct 10. doi: 10.1038/s41386-025-02261.
   PubMed         Abstract available
   
   
9. CHATTERJEE S, Soria M, Norville ZC, Thompson KR, et al
   Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M(1) and M(4) receptors.
   Neuropsychopharmacology. 2025 Oct 4. doi: 10.1038/s41386-025-02256.
   PubMed         Abstract available
   
   

   
   PLoS One

10. DONATH VM, Ries ES, Mariegaard L, Kristensen TD, et al
    Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study.
    PLoS One. 2025;20:e0331632.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

11. MONTI P, Iodice S, Capuzzi E, Borroni E, et al
    Short-term exposure to particulate matter and apparent temperature is associated with schizophrenia severity in Italy.
    Psychiatry Res. 2025;353:116735.
    PubMed         Abstract available
    
    
12. XUE J, Zhai Z, Li X, Zhu Y, et al
    Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial.
    Psychiatry Res. 2025;353:116756.
    PubMed         Abstract available
    
    

    
    Psychol Med

13. ZHANG Y, Wang H, Cai M, Wang W, et al
    From risk to chronicity: genetic and neuroimaging insights into the evolving patterns of spontaneous brain activity in schizophrenia.
    Psychol Med. 2025;55:e306.
    PubMed         Abstract available
    
    

    
    Schizophr Res

14. STANICA AM, Remiszewski N, Shen C, Sponheim SR, et al
    Subcortical brain abnormalities and cognitive function in individuals with psychosis and their unaffected relatives: A normative modeling approach.
    Schizophr Res. 2025;285:255-264.
    PubMed         Abstract available
    
    
15. ALTINOK DCA, Fritze S, Volkmer S, Brandt GA, et al
    Emotional maltreatment shapes the relationship between psychosocial functioning and hippocampal structure in schizophrenia spectrum disorders.
    Schizophr Res. 2025;285:242-254.
    PubMed         Abstract available
    
    
16. CROWLEY P, Healy J, McNamara N, Twomey R, et al
    Duration of active psychosis: A scoping review of definition, measurement, and relationship with outcomes.
    Schizophr Res. 2025;285:232-241.
    PubMed         Abstract available
    
    
17. KAMPHUIS S, Arias-Magnasco A, Gangadin S, Begemann M, et al
    Association between the exposome score for schizophrenia and functioning in remitted first-episode psychosis: results from the HAMLETT study.
    Schizophr Res. 2025;285:223-231.
    PubMed         Abstract available
    
    
18. XIA W, Hau C, Burns J, Ryan S, et al
    Smartphone intervention apps for schizophrenia: A review of the academic literature and app stores.
    Schizophr Res. 2025;285:204-214.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.